Cargando…
Infections in neutropenic patients I: Aetiology
Improvement in supportive care including the introduction of new antibiotics, antiviral and antifungal agents and haematopoietic growth factors have all contributed to a decreased chemotherapy-related mortality and morbidity in cancer patients. However, infections/septic shock during neutropenia sti...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Humana Press
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101772/ https://www.ncbi.nlm.nih.gov/pubmed/8832528 http://dx.doi.org/10.1007/BF02990570 |
_version_ | 1783511692885360640 |
---|---|
author | Engervall, Per Björkholm, Magnus |
author_facet | Engervall, Per Björkholm, Magnus |
author_sort | Engervall, Per |
collection | PubMed |
description | Improvement in supportive care including the introduction of new antibiotics, antiviral and antifungal agents and haematopoietic growth factors have all contributed to a decreased chemotherapy-related mortality and morbidity in cancer patients. However, infections/septic shock during neutropenia still constitutes a major threat to these patients. Most patients develop fever during neutropenia and in 20–40% a manifest bacteremia is documented. In patients with prolonged neutropenia, the risk for fungal infections is increased. The spectrum of bacterial, fungal and viral infections in the neutropenic patient is reviewed. |
format | Online Article Text |
id | pubmed-7101772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1995 |
publisher | Humana Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-71017722020-03-31 Infections in neutropenic patients I: Aetiology Engervall, Per Björkholm, Magnus Med Oncol Review Improvement in supportive care including the introduction of new antibiotics, antiviral and antifungal agents and haematopoietic growth factors have all contributed to a decreased chemotherapy-related mortality and morbidity in cancer patients. However, infections/septic shock during neutropenia still constitutes a major threat to these patients. Most patients develop fever during neutropenia and in 20–40% a manifest bacteremia is documented. In patients with prolonged neutropenia, the risk for fungal infections is increased. The spectrum of bacterial, fungal and viral infections in the neutropenic patient is reviewed. Humana Press 1995 /pmc/articles/PMC7101772/ /pubmed/8832528 http://dx.doi.org/10.1007/BF02990570 Text en © Chapman & Hall 1995 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Engervall, Per Björkholm, Magnus Infections in neutropenic patients I: Aetiology |
title | Infections in neutropenic patients I: Aetiology |
title_full | Infections in neutropenic patients I: Aetiology |
title_fullStr | Infections in neutropenic patients I: Aetiology |
title_full_unstemmed | Infections in neutropenic patients I: Aetiology |
title_short | Infections in neutropenic patients I: Aetiology |
title_sort | infections in neutropenic patients i: aetiology |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101772/ https://www.ncbi.nlm.nih.gov/pubmed/8832528 http://dx.doi.org/10.1007/BF02990570 |
work_keys_str_mv | AT engervallper infectionsinneutropenicpatientsiaetiology AT bjorkholmmagnus infectionsinneutropenicpatientsiaetiology |